Beaumont Children’s Hospital Awarded $20,000 from CureSearch for cancer research

5/8/2014

Grant awarded through Clinical Trial Advancement Award Program


Dr. Gowans

CureSearch for Children’s Cancer has awarded a $20,000 grant to Beaumont Children’s Hospital to help fund therapeutic clinical trials.

CureSearch and Beaumont believe clinical trials are essential to help children with cancer. In 2013, CureSearch supported 78 hospitals nationwide through their Clinical Trial Advancement Awards Program.

Explains Kate Gowans, M.D., section head, Pediatric Hematology and Oncology, Beaumont Children’s Hospital, “We’re grateful to CureSearch for this grant. CureSearch clinical trials offer hope for families whose children participate in cancer research. These studies reach patients, saving lives and changing the odds for kids today, and far into the future. This funding enables our group to open additional studies, allowing more pediatric oncology patients and their families the opportunity to participate in research trials.”

Among adults, less than five percent of those with cancer are enrolled in clinical trials. Yet for children, more than 60 percent of those with cancer participate in some form of clinical research. Because clinical trials can save children’s lives, CureSearch supports local hospitals, like Beaumont Children’s Hospital, with Clinical Trial Advancement Awards.

Beaumont Children’s Hospital doctors provide comprehensive care for pediatric oncology patients, including evaluation and treatment. They specialize in the diagnosis and treatment of blood disorders and cancers in children, using a multidisciplinary approach which includes medical, surgical and radiation oncology.

About CureSearch

CureSearch for Children’s Cancer is a national nonprofit foundation whose mission is to fund and support children’s cancer research and provide information and resources to all those affected by children’s cancer. CureSearch raises funds for promising research conducted at more than 78 hospitals in the United States, participating in collaborative clinical trials. Through the CureSearch Acceleration Initiative and Young Investigator Program, CureSearch also funds basic and translational research that offers the greatest potential to design treatments and improve outcomes for children with difficult-to-treat cancers.Visit www.CureSearch.org for more information.

About Beaumont’s Cancer Program Beaumont’s comprehensive cancer program combines the expertise of surgical, medical and radiation oncologists to offer cancer prevention counseling, diagnosis and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 51Community Clinical Oncology Programs in the country designated by the National Cancer Institute to provide patients with access to leading-edge cancer clinical research trials. Beaumont is designated as a Blue Cross Center of Distinction for the Treatment of Rare and Complex Cancers. Beaumont, Royal Oak and Troy are recognized by U.S. News & World Report as “high performing” hospitals for cancer care. Find out more at http://cancer.beaumont.edu/.